Eris Biotech Funding & Investors
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.
erisbio.comTotal Amount Raised: $500,000
Eris Biotech Funding Rounds
Pre Seed
$500,000
Pre Seed Investors
Y Combinator
Funding info provided by Diffbot.